Hasil Pencarian - Mathias Vrolix

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    Final 36-Month Outcomes from the Multicenter DynamX Study Evaluating a Novel Thin-Strut Novolimus-Eluting Coronary Bioadaptor System and Supporting Preclinical Data

    Final 36-Month Outcomes from the Multicenter DynamX Study Evaluating a Novel Thin-Strut Novolimus-Eluting Coronary Bioadaptor System and Supporting Preclinical Data oleh Stefan Verheye, Mathias Vrolix, Matteo Montorfano, Francesco Giannini, Francesco Bedogni, Christophe Dubois, Bernard De Bruyne, Ricardo A. Costa, Daniel Chamié, José Ribamar Costa Jr, Alexandre Abizaid, Antonio Colombo

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTResearch in Context

    First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-mo... oleh Shigeru Saito, Johan Bennett, Holger M. Nef, Mark Webster, Atsuo Namiki, Akihiko Takahashi, Tsunekazu Kakuta, Seiji Yamazaki, Yoshisato Shibata, Douglas Scott, Mathias Vrolix, Madhav Menon, Helge Möllmann, Nikos Werner, Antoinette Neylon, Zlatko Mehmedbegovic, Pieter C. Smits, Marie-Claude Morice, Stefan Verheye

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: